Xylem Inc. XYL
96.27 USD -0.99 (-1.02%)
At closeNov 3, 2026, 4:42 PM EST
96.27 0.00 0.00%
After hours · Nov 3, 4:42 PM ET
95.01 Day range 97.26
87.40 52-week range 152.44
- YTD
- -29.31%
- 1 year
- -35.43%
Analyst view
Consensus: buy
Buy
Price target (mean) 125.44 +30.3% upside
Now 96.27
- Target (low)
- 90.00
- Target (mean)
- 125.44
- Target (high)
- 180.00
Ratings (0m) 21 13 buy · 7 hold · 1 sell
- Strong buy3
- Buy10
- Hold7
- Sell0
- Strong sell1
Recommendation trend
- This month 21
- 1 month ago 21
- 2 months ago 21
- 3 months ago 21
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.42 | 1.34 – 1.46 | 1.42 | +0.1% | 2.29B | -4.5% | 15 |
| Next quarter | 1.15 | 1.05 – 1.22 | 1.12 | +3.1% | 2.13B | +0.3% | 14 |
| Current year | 5.43 | 5.35 – 5.45 | 5.08 | +6.9% | 8.95B | -0.9% | 16 |
| Next year | 5.90 | 5.44 – 6.40 | 5.43 | +8.7% | 9.30B | +3.9% | 20 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 29, 2026 | Barclays | Downgrade | Overweight | Equal-Weight |
| Oct 28, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 28, 2026 | BNP Paribas | Maintained | Outperform | Outperform |
| Oct 28, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Oct 28, 2026 | Stifel | Maintained | Buy | Buy |
| Oct 28, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 28, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 28, 2026 | JP Morgan | Downgrade | Neutral | Underweight |
| Oct 19, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 15, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Oct 14, 2026 | Oppenheimer | Reiterated | Outperform | Outperform |
| Oct 14, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 13, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 12, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 24, 2026 | Jefferies | Maintained | Buy | Buy |
| Aug 13, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 30, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 29, 2026 | Stifel | Maintained | Buy | Buy |
| Jul 29, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Jul 29, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 29, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 29, 2026 | Baird | Maintained | Outperform | Outperform |
| Jul 20, 2026 | Stifel | Maintained | Buy | Buy |
| Jul 16, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 25, 2026 | Jefferies | Upgrade | Hold | Buy |
| Apr 29, 2026 | UBS | Maintained | Neutral | Neutral |
| Apr 29, 2026 | Citigroup | Maintained | Buy | Buy |
| Apr 29, 2026 | Oppenheimer | Maintained | Outperform | Outperform |